Wynitde 1mg

Wyntide 1mg Pen Injection contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. The product is also listed in India for chronic weight management in eligible adults when used with a reduced-calorie diet and increased physical activity. Wyntide 1mg Pen Injection contains semaglutide 1.34 mg/mL and is supplied as a 3 mL prefilled pen. The 1mg dose is generally reached after treatment has been started at a lower dose and increased gradually according to the prescribed treatment schedule.

Wyntide 1mg Pen Injection may be used: To improve blood sugar control in adults with type 2 diabetes mellitus. As an adjunct to diet and exercise when blood sugar remains insufficiently controlled. For chronic weight management in eligible adults with obesity or overweight with at least one weight-related health condition, along with a reduced-calorie diet and increased physical activity. The indication for which Wyntide is prescribed should be determined by your doctor based on your medical condition and treatment needs.

Wyntide 1mg Pen Injection is administered under the skin once a week. It can be injected into the abdomen, thigh or upper arm and can be used at any time of day, with or without food. Try to use it on the same day each week. Treatment with semaglutide is generally started at a lower dose and increased gradually. The 1mg dose is used after the initial treatment stages when prescribed by the doctor. Do not start at 1mg or change your dose without medical advice. Before each injection, check the solution through the pen window. It should be clear and colourless. Follow the instructions provided with the pen for attaching and removing the needle.

The most common side effects of Wyntide include: Nausea Vomiting Diarrhoea Constipation Abdominal pain These effects are particularly common when treatment is started or the dose is increased and may become less troublesome as your body adjusts to the medicine. Contact your doctor if you develop severe or persistent abdominal pain, repeated vomiting, symptoms of dehydration or changes in vision. Seek immediate medical attention if you develop symptoms of a serious allergic reaction.

Pregnancy Unsafe Wyntide should not be used during pregnancy. If you are planning a pregnancy, speak to your doctor about stopping treatment. Semaglutide should generally be discontinued at least 2 months before a planned pregnancy. Breast Feeding Consult Your Doctor Tell your doctor if you are breastfeeding before using Wyntide. Your doctor will decide whether treatment is appropriate based on your individual circumstances. Lungs Consult Your Doctor Tell your doctor if you are scheduled for surgery or a procedure requiring general anaesthesia or deep sedation. Semaglutide delays gastric emptying, which may increase the risk of stomach contents entering the lungs during such procedures. Liver Consult Your Doctor Tell your doctor if you have liver disease before starting Wyntide. Your doctor will assess whether the medicine is suitable for you. Alcohol Unsafe Avoid excessive alcohol consumption while using Wyntide. Alcohol can affect blood glucose control and may worsen gastrointestinal symptoms such as nausea and vomiting. Driving Consult Your Doctor Wyntide does not usually affect your ability to drive. However, hypoglycaemia can occur when semaglutide is used with insulin or sulf

2 - 8°C